Today’s Solutions: October 04, 2024

Skin conditions

This app can save time and lives by diagnosing skin conditions

After a concerning brush with melanoma, where a lengthy test dangerously delayed her treatment, Susan Conover began her studies in skin diseases and dermatology. She explored technological solutions to skin problems in the MIT System Design and Management graduate program and then founded Piction Read More...

Harvard scientists thrilled wi

Harvard scientists thrilled with new personalized cancer vaccine

Although the pandemic has put many things on hold, it has also spurred advancement in a variety of fields. For instance, there’s been a lot of interest and investment in vaccine technology for coronavirus, but the Covid-19 virus is not the only illness we can fend off with the surge of new Read More...

New skin cancer vaccine could

New skin cancer vaccine could prevent melanoma from coming back

If caught early, the highly-aggressive form of skin cancer known as melanoma is highly curable, with a 5-year survival rate of 92 percent. There is always a risk of it coming back, but that risk could be massively reduced thanks to a new skin cancer vaccine. The vaccine was developed by the New Read More...

Late-stage melanoma was once u

Late-stage melanoma was once untreatable. Immunotherapy is changing that

Melanoma seems to have found its match in immunotherapy, a type of treatment designed to help the immune system fight cancer. Just a decade ago, only one-in-20 patients would live for five years after being diagnosed with late-stage melanoma, with most dying in months. But drugs designed to trigger Read More...

Four ways to protect yourself

Four ways to protect yourself from skin cancer (we’re not talking sunscreen)

One in five Americans will be diagnosed with skin cancer during their lifetime. Many people don't know this, but skin cancer is the most prevalent cancer worldwide, and in the United States, there are more new cases of skin cancer than breast, prostate, lung, and colon cancers combined. Research Read More...